BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Liu S, Premont RT, Kontos CD, Zhu S, Rockey DC. A crucial role for GRK2 in regulation of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med. 2005;11:952-958. [PMID: 16142243 DOI: 10.1038/nm1289] [Cited by in Crossref: 186] [Cited by in F6Publishing: 169] [Article Influence: 10.9] [Reference Citation Analysis]
Number Citing Articles
1 Gao Z, Min X, Kim K, Liu H, Hu L, Wu C, Zhang X. The tyrosine phosphorylation of GRK2 is responsible for activated D2R-mediated insulin resistance. Biochemical and Biophysical Research Communications 2022. [DOI: 10.1016/j.bbrc.2022.08.056] [Reference Citation Analysis]
2 Zhai R, Snyder J, Montgomery S, Sato PY. Double life: How GRK2 and β-arrestin signaling participate in diseases. Cellular Signalling 2022. [DOI: 10.1016/j.cellsig.2022.110333] [Reference Citation Analysis]
3 Li Y, Yang B, Zhang X, Shen X, Ma Y, Jing L. Lycium barbarum polysaccharide antagonizes cardiomyocyte apoptosis by inhibiting the upregulation of GRK2 induced by I/R injury, and salvage mitochondrial fission/fusion imbalance and AKT/eNOS signaling. Cellular Signalling 2022;92:110252. [DOI: 10.1016/j.cellsig.2022.110252] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Li N, Shan S, Li XQ, Chen TT, Qi M, Zhang SN, Wang ZY, Zhang LL, Wei W, Sun WY. G Protein-Coupled Receptor Kinase 2 as Novel Therapeutic Target in Fibrotic Diseases. Front Immunol 2021;12:822345. [PMID: 35111168 DOI: 10.3389/fimmu.2021.822345] [Reference Citation Analysis]
5 Abd Alla J, Quitterer U. The RAF Kinase Inhibitor Protein (RKIP): Good as Tumour Suppressor, Bad for the Heart. Cells 2022;11:654. [PMID: 35203304 DOI: 10.3390/cells11040654] [Reference Citation Analysis]
6 Baksheeva VE, Baldin AV, Zalevsky AO, Nazipova AA, Kazakov AS, Vladimirov VI, Gorokhovets NV, Devred F, Philippov PP, Bazhin AV, Golovin AV, Zamyatnin AA Jr, Zinchenko DV, Tsvetkov PO, Permyakov SE, Zernii EY. Disulfide Dimerization of Neuronal Calcium Sensor-1: Implications for Zinc and Redox Signaling. Int J Mol Sci 2021;22:12602. [PMID: 34830487 DOI: 10.3390/ijms222212602] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
7 Kuai J, Han C, Wei W. Potential Regulatory Roles of GRK2 in Endothelial Cell Activity and Pathological Angiogenesis. Front Immunol 2021;12:698424. [PMID: 34335610 DOI: 10.3389/fimmu.2021.698424] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
8 Chaudhary PK, Kim S. The GRKs Reactome: Role in Cell Biology and Pathology. Int J Mol Sci 2021;22:3375. [PMID: 33806057 DOI: 10.3390/ijms22073375] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
9 Marrache MK, Rockey DC. Statins for treatment of chronic liver disease. Curr Opin Gastroenterol 2021;37:200-7. [PMID: 33654016 DOI: 10.1097/MOG.0000000000000716] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Bledzka KM, Manaserh IH, Grondolsky J, Pfleger J, Roy R, Gao E, Chuprun JK, Koch WJ, Schumacher SM. A peptide of the amino-terminus of GRK2 induces hypertrophy and yet elicits cardioprotection after pressure overload. J Mol Cell Cardiol 2021;154:137-53. [PMID: 33548241 DOI: 10.1016/j.yjmcc.2021.01.004] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
11 Laganà M, Schlecht-Louf G, Bachelerie F. The G Protein-Coupled Receptor Kinases (GRKs) in Chemokine Receptor-Mediated Immune Cell Migration: From Molecular Cues to Physiopathology. Cells 2021;10:E75. [PMID: 33466410 DOI: 10.3390/cells10010075] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Gunarathne LS, Rajapaksha H, Shackel N, Angus PW, Herath CB. Cirrhotic portal hypertension: From pathophysiology to novel therapeutics. World J Gastroenterol 2020; 26(40): 6111-6140 [PMID: 33177789 DOI: 10.3748/wjg.v26.i40.6111] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 9] [Article Influence: 6.5] [Reference Citation Analysis]
13 Henry SA, Crivello S, Nguyen TM, Cybulska M, Hoang NS, Nguyen M, Badial T, Emami N, Awada N, Woodward JF, So CH. G protein-coupled receptor kinase 2 modifies the ability of Caenorhabditis elegans to survive oxidative stress. Cell Stress Chaperones 2021;26:187-97. [PMID: 33064264 DOI: 10.1007/s12192-020-01168-z] [Reference Citation Analysis]
14 Han CC, Liu Q, Zhang Y, Li YF, Cui DQ, Luo TT, Zhang YW, Wang XM, Wang C, Ma Y, Wei W. CP-25 inhibits PGE2-induced angiogenesis by down-regulating EP4/AC/cAMP/PKA-mediated GRK2 translocation. Clin Sci (Lond) 2020;134:331-47. [PMID: 31967309 DOI: 10.1042/CS20191032] [Cited by in Crossref: 12] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
15 Liu S, Luttrell LM, Premont RT, Rockey DC. β-Arrestin2 is a critical component of the GPCR-eNOS signalosome. Proc Natl Acad Sci U S A 2020;117:11483-92. [PMID: 32404425 DOI: 10.1073/pnas.1922608117] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 5.0] [Reference Citation Analysis]
16 Pathania AS, Ren X, Mahdi MY, Shackleford GM, Erdreich-Epstein A. GRK2 promotes growth of medulloblastoma cells and protects them from chemotherapy-induced apoptosis. Sci Rep 2019;9:13902. [PMID: 31554835 DOI: 10.1038/s41598-019-50157-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
17 Penela P, Ribas C, Sánchez-Madrid F, Mayor F Jr. G protein-coupled receptor kinase 2 (GRK2) as a multifunctional signaling hub. Cell Mol Life Sci 2019;76:4423-46. [PMID: 31432234 DOI: 10.1007/s00018-019-03274-3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 31] [Article Influence: 8.7] [Reference Citation Analysis]
18 Ribera J, Rodríguez-Vita J, Cordoba B, Portolés I, Casals G, Casals E, Jiménez W, Puntes V, Morales-Ruiz M. Functionalized cerium oxide nanoparticles mitigate the oxidative stress and pro-inflammatory activity associated to the portal vein endothelium of cirrhotic rats. PLoS One 2019;14:e0218716. [PMID: 31233564 DOI: 10.1371/journal.pone.0218716] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 2.7] [Reference Citation Analysis]
19 Murga C, Arcones AC, Cruces-Sande M, Briones AM, Salaices M, Mayor F Jr. G Protein-Coupled Receptor Kinase 2 (GRK2) as a Potential Therapeutic Target in Cardiovascular and Metabolic Diseases. Front Pharmacol 2019;10:112. [PMID: 30837878 DOI: 10.3389/fphar.2019.00112] [Cited by in Crossref: 30] [Cited by in F6Publishing: 40] [Article Influence: 10.0] [Reference Citation Analysis]
20 Lieu M, Koch WJ. GRK2 and GRK5 as therapeutic targets and their role in maladaptive and pathological cardiac hypertrophy. Expert Opin Ther Targets 2019;23:201-14. [PMID: 30701991 DOI: 10.1080/14728222.2019.1575363] [Cited by in Crossref: 7] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
21 Hendrickx JO, van Gastel J, Leysen H, Santos-Otte P, Premont RT, Martin B, Maudsley S. GRK5 - A Functional Bridge Between Cardiovascular and Neurodegenerative Disorders. Front Pharmacol 2018;9:1484. [PMID: 30618771 DOI: 10.3389/fphar.2018.01484] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
22 Xiao FH, Chen XQ, He YH, Kong QP. Accelerated DNA methylation changes in middle-aged men define sexual dimorphism in human lifespans. Clin Epigenetics 2018;10:133. [PMID: 30373676 DOI: 10.1186/s13148-018-0573-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.5] [Reference Citation Analysis]
23 Leysen H, van Gastel J, Hendrickx JO, Santos-Otte P, Martin B, Maudsley S. G Protein-Coupled Receptor Systems as Crucial Regulators of DNA Damage Response Processes. Int J Mol Sci 2018;19:E2919. [PMID: 30261591 DOI: 10.3390/ijms19102919] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
24 Wan ZH, Zhang YJ, Chen L, Guo YL, Li GH, Wu D, Wang Y. G protein-coupled receptor kinase 2 inhibition improves erectile function through amelioration of endothelial dysfunction and oxidative stress in a rat model of type 2 diabetes. Asian J Androl 2018. [PMID: 30226217 DOI: 10.4103/aja.aja_69_18] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
25 Yu Q, Gratzke C, Wang Y, Herlemann A, Strittmatter F, Rutz B, Stief CG, Hennenberg M. Inhibition of prostatic smooth muscle contraction by the inhibitor of G protein-coupled receptor kinase 2/3, CMPD101. European Journal of Pharmacology 2018;831:9-19. [DOI: 10.1016/j.ejphar.2018.04.022] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
26 Taguchi K, Bessho N, Hida M, Narimatsu H, Matsumoto T, Kobayashi T. Inactivation of MAPK in epididymal fat and amelioration of triglyceride secretion by injection of GRK2 siRNA in ob/ob mice. Naunyn Schmiedebergs Arch Pharmacol 2018;391:1075-83. [PMID: 29946903 DOI: 10.1007/s00210-018-1530-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
27 Crassini K, Pyke T, Shen Y, Stevenson WS, Christopherson RI, Mulligan SP, Best OG. Inhibition of the Raf-1 kinase inhibitory protein (RKIP) by locostatin induces cell death and reduces the CXCR4-mediated migration of chronic lymphocytic leukemia cells. Leuk Lymphoma 2018;59:2917-28. [PMID: 29911936 DOI: 10.1080/10428194.2018.1455974] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
28 Wang HJ, Gu HX, Eijkelkamp N, Heijnen CJ, Kavelaars A. Low GRK2 Underlies Hyperalgesic Priming by Glial Cell-Derived Neurotrophic Factor. Front Pharmacol 2018;9:592. [PMID: 29922165 DOI: 10.3389/fphar.2018.00592] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
29 Schumacher SM, Koch WJ. Noncanonical Roles of G Protein-coupled Receptor Kinases in Cardiovascular Signaling. J Cardiovasc Pharmacol 2017;70:129-41. [PMID: 28328744 DOI: 10.1097/FJC.0000000000000483] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
30 Taguchi K, Bessho N, Hasegawa M, Narimatsu H, Matsumoto T, Kobayashi T. Co-treatment with clonidine and a GRK2 inhibitor prevented rebound hypertension and endothelial dysfunction after withdrawal in diabetes. Hypertens Res 2018;41:263-74. [DOI: 10.1038/s41440-018-0016-6] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
31 Qi X, Guo Y, Song Y, Yu C, Zhao L, Fang L, Kong D, Zhao J, Gao L. Follicle-stimulating hormone enhances hepatic gluconeogenesis by GRK2-mediated AMPK hyperphosphorylation at Ser485 in mice. Diabetologia 2018;61:1180-92. [PMID: 29442133 DOI: 10.1007/s00125-018-4562-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 17] [Article Influence: 3.5] [Reference Citation Analysis]
32 Mayor F, Cruces-sande M, Arcones AC, Vila-bedmar R, Briones AM, Salaices M, Murga C. G protein-coupled receptor kinase 2 (GRK2) as an integrative signalling node in the regulation of cardiovascular function and metabolic homeostasis. Cellular Signalling 2018;41:25-32. [DOI: 10.1016/j.cellsig.2017.04.002] [Cited by in Crossref: 25] [Cited by in F6Publishing: 27] [Article Influence: 6.3] [Reference Citation Analysis]
33 Li W, Jia X, Shen C, Zhang M, Xu J, Shang Y, Zhu K, Hu M, Yan Q, Qin D, Lee MS, Zhu J, Lu H, Krueger BJ, Renne R, Gao SJ, Lu C. A KSHV microRNA enhances viral latency and induces angiogenesis by targeting GRK2 to activate the CXCR2/AKT pathway. Oncotarget 2016;7:32286-305. [PMID: 27058419 DOI: 10.18632/oncotarget.8591] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
34 Cannavo A, Komici K, Bencivenga L, D'amico ML, Gambino G, Liccardo D, Ferrara N, Rengo G. GRK2 as a therapeutic target for heart failure. Expert Opin Ther Targets 2018;22:75-83. [PMID: 29166798 DOI: 10.1080/14728222.2018.1406925] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 6.4] [Reference Citation Analysis]
35 Chang FM, Wang YP, Lang HC, Tsai CF, Hou MC, Lee FY, Lu CL. Statins decrease the risk of decompensation in hepatitis B virus- and hepatitis C virus-related cirrhosis: A population-based study. Hepatology 2017;66:896-907. [PMID: 28318053 DOI: 10.1002/hep.29172] [Cited by in Crossref: 61] [Cited by in F6Publishing: 62] [Article Influence: 12.2] [Reference Citation Analysis]
36 Steury MD, Lucas PC, McCabe LR, Parameswaran N. G-protein-coupled receptor kinase-2 is a critical regulator of TNFα signaling in colon epithelial cells. Biochem J 2017;474:2301-13. [PMID: 28572156 DOI: 10.1042/BCJ20170093] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
37 Giusti S, Mazzei D, Cacopardo L, Mattei G, Domenici C, Ahluwalia A. Environmental Control in Flow Bioreactors. Processes 2017;5:16. [DOI: 10.3390/pr5020016] [Cited by in Crossref: 11] [Cited by in F6Publishing: 6] [Article Influence: 2.2] [Reference Citation Analysis]
38 Lin SB, Zhou L, Liang ZY, Zhou WX, Jin Y. Expression of GRK2 and IGF1R in hepatocellular carcinoma: clinicopathological and prognostic significance. J Clin Pathol 2017;70:754-9. [PMID: 28202495 DOI: 10.1136/jclinpath-2016-203998] [Cited by in Crossref: 11] [Cited by in F6Publishing: 15] [Article Influence: 2.2] [Reference Citation Analysis]
39 Liu S, Premont RT, Singh S, Rockey DC. Caveolin 1 and G-Protein-Coupled Receptor Kinase-2 Coregulate Endothelial Nitric Oxide Synthase Activity in Sinusoidal Endothelial Cells. Am J Pathol 2017;187:896-907. [PMID: 28162981 DOI: 10.1016/j.ajpath.2016.11.017] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.6] [Reference Citation Analysis]
40 Nogués L, Reglero C, Rivas V, Neves M, Penela P, Mayor F. G-Protein–Coupled Receptor Kinase 2 as a Potential Modulator of the Hallmarks of Cancer. Mol Pharmacol 2017;91:220-8. [DOI: 10.1124/mol.116.107185] [Cited by in Crossref: 27] [Cited by in F6Publishing: 25] [Article Influence: 4.5] [Reference Citation Analysis]
41 Yang J, Villar VA, Armando I, Jose PA, Zeng C. G Protein-Coupled Receptor Kinases: Crucial Regulators of Blood Pressure. J Am Heart Assoc 2016;5:e003519. [PMID: 27390269 DOI: 10.1161/JAHA.116.003519] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 2.5] [Reference Citation Analysis]
42 Zhou L, Wang MY, Liang ZY, Zhou WX, You L, Pan BJ, Liao Q, Zhao YP. G-protein-coupled receptor kinase 2 in pancreatic cancer: clinicopathologic and prognostic significance. Hum Pathol 2016;56:171-7. [PMID: 27346572 DOI: 10.1016/j.humpath.2016.06.012] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 2.3] [Reference Citation Analysis]
43 Polhemus DJ, Gao J, Scarborough AL, Trivedi R, McDonough KH, Goodchild TT, Smart F, Kapusta DR, Lefer DJ. Radiofrequency Renal Denervation Protects the Ischemic Heart via Inhibition of GRK2 and Increased Nitric Oxide Signaling. Circ Res 2016;119:470-80. [PMID: 27296507 DOI: 10.1161/CIRCRESAHA.115.308278] [Cited by in Crossref: 27] [Cited by in F6Publishing: 29] [Article Influence: 4.5] [Reference Citation Analysis]
44 Nair H, Berzigotti A, Bosch J. Emerging therapies for portal hypertension in cirrhosis. Expert Opin Emerg Drugs 2016;21:167-81. [PMID: 27148904 DOI: 10.1080/14728214.2016.1184647] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 2.5] [Reference Citation Analysis]
45 Hullmann J, Traynham CJ, Coleman RC, Koch WJ. The expanding GRK interactome: Implications in cardiovascular disease and potential for therapeutic development. Pharmacol Res 2016;110:52-64. [PMID: 27180008 DOI: 10.1016/j.phrs.2016.05.008] [Cited by in Crossref: 41] [Cited by in F6Publishing: 40] [Article Influence: 6.8] [Reference Citation Analysis]
46 Rockey DC. A New Treatment for Portal Hypertension? Gastroenterology 2016;150:1077-80. [DOI: 10.1053/j.gastro.2016.03.015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
47 Pauta M, Rotllan N, Fernández-Hernando A, Langhi C, Ribera J, Lu M, Boix L, Bruix J, Jimenez W, Suárez Y, Ford DA, Baldán A, Birnbaum MJ, Morales-Ruiz M, Fernández-Hernando C. Akt-mediated foxo1 inhibition is required for liver regeneration. Hepatology 2016;63:1660-74. [PMID: 26473496 DOI: 10.1002/hep.28286] [Cited by in Crossref: 37] [Cited by in F6Publishing: 32] [Article Influence: 6.2] [Reference Citation Analysis]
48 Zha Z, Han XR, Smith MD, Lei QY, Guan KL, Xiong Y. Hypertension-associated C825T polymorphism impairs the function of Gβ3 to target GRK2 ubiquitination. Cell Discov 2016;2:16005. [PMID: 27462452 DOI: 10.1038/celldisc.2016.5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
49 Singh M, Singh AK, Pandey P, Chandra S, Singh KA, Gambhir IS. Molecular genetics of essential hypertension. Clin Exp Hypertens 2016;38:268-77. [PMID: 27028574 DOI: 10.3109/10641963.2015.1116543] [Cited by in Crossref: 43] [Cited by in F6Publishing: 41] [Article Influence: 7.2] [Reference Citation Analysis]
50 Horinouchi T, Hoshi A, Harada T, Higa T, Karki S, Terada K, Higashi T, Mai Y, Nepal P, Mazaki Y, Miwa S. Endothelin-1 suppresses insulin-stimulated Akt phosphorylation and glucose uptake via GPCR kinase 2 in skeletal muscle cells. Br J Pharmacol 2016;173:1018-32. [PMID: 26660861 DOI: 10.1111/bph.13406] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
51 Gui YJ, Liao CX, Liu Q, Guo Y, Xu DY. RKIP corrects impaired beta (2)-adrenergic receptor vasodilatation in hypertension by downregulation of GRK2. Int J Cardiol 2016;207:359-60. [PMID: 26820366 DOI: 10.1016/j.ijcard.2016.01.191] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
52 Singh S, Liu S, Rockey DC. Caveolin-1 is upregulated in hepatic stellate cells but not sinusoidal endothelial cells after liver injury. Tissue Cell 2016;48:126-32. [PMID: 26847875 DOI: 10.1016/j.tice.2015.12.006] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
53 Lucas E, Cruces-sande M, Briones AM, Salaices M, Mayor F, Murga C, Vila-bedmar R. Molecular physiopathology of obesity-related diseases: multi-organ integration by GRK2. Archives of Physiology and Biochemistry 2015;121:163-77. [DOI: 10.3109/13813455.2015.1107589] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
54 Hu M, Wang C, Li W, Lu W, Bai Z, Qin D, Yan Q, Zhu J, Krueger BJ, Renne R, Gao SJ, Lu C. A KSHV microRNA Directly Targets G Protein-Coupled Receptor Kinase 2 to Promote the Migration and Invasion of Endothelial Cells by Inducing CXCR2 and Activating AKT Signaling. PLoS Pathog 2015;11:e1005171. [PMID: 26402907 DOI: 10.1371/journal.ppat.1005171] [Cited by in Crossref: 52] [Cited by in F6Publishing: 53] [Article Influence: 7.4] [Reference Citation Analysis]
55 Zha Z, Han X, Smith MD, Liu Y, Giguère PM, Kopanja D, Raychaudhuri P, Siderovski DP, Guan KL, Lei QY, Xiong Y. A Non-Canonical Function of Gβ as a Subunit of E3 Ligase in Targeting GRK2 Ubiquitylation. Mol Cell 2015;58:794-803. [PMID: 25982117 DOI: 10.1016/j.molcel.2015.04.017] [Cited by in Crossref: 20] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
56 Theodorakis NG, Wang YN, Korshunov VA, Maluccio MA, Skill NJ. Thalidomide ameliorates portal hypertension via nitric oxide synthase independent reduced systolic blood pressure. World J Gastroenterol 2015; 21(14): 4126-4135 [PMID: 25892862 DOI: 10.3748/wjg.v21.i14.4126] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
57 Fernandez M. Molecular pathophysiology of portal hypertension. Hepatology 2015;61:1406-15. [PMID: 25092403 DOI: 10.1002/hep.27343] [Cited by in Crossref: 77] [Cited by in F6Publishing: 68] [Article Influence: 11.0] [Reference Citation Analysis]
58 Gracia-Sancho J, Maeso-Díaz R, Fernández-Iglesias A, Navarro-Zornoza M, Bosch J. New cellular and molecular targets for the treatment of portal hypertension. Hepatol Int. 2015;9:183-191. [PMID: 25788198 DOI: 10.1007/s12072-015-9613-5] [Cited by in Crossref: 42] [Cited by in F6Publishing: 42] [Article Influence: 6.0] [Reference Citation Analysis]
59 Subramanian H, Gupta K, Parameswaran N, Ali H. Regulation of Fc∈RI signaling in mast cells by G protein-coupled receptor kinase 2 and its RH domain. J Biol Chem 2014;289:20917-27. [PMID: 24904059 DOI: 10.1074/jbc.M113.523969] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
60 Rockey DC. Endothelial Dysfunction in Advanced Liver Disease. The American Journal of the Medical Sciences 2015;349:6-16. [DOI: 10.1097/maj.0000000000000403] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
61 Du QH, Han L, Jiang JJ, Xu Y, Li WH, Li PT, Wang XY, Jia X. Glytan decreases portal pressure via mesentery vasoconstriction in portal hypertensive rats. World J Gastroenterol 2014; 20(44): 16674-16682 [PMID: 25469036 DOI: 10.3748/wjg.v20.i44.16674] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
62 Kawanaka H, Akahoshi T, Kinjo N, Iguchi T, Ninomiya M, Yamashita YI, Ikegami T, Yoshizumi T, Shirabe K, Maehara Y. Effect of laparoscopic splenectomy on portal haemodynamics in patients with liver cirrhosis and portal hypertension. Br J Surg 2014;101:1585-93. [PMID: 25200126 DOI: 10.1002/bjs.9622] [Cited by in Crossref: 32] [Cited by in F6Publishing: 30] [Article Influence: 4.0] [Reference Citation Analysis]
63 Shafiei MS, Lui S, Rockey DC. Integrin-linked kinase regulates endothelial cell nitric oxide synthase expression in hepatic sinusoidal endothelial cells. Liver Int. 2015;35:1213-1221. [PMID: 24906011 DOI: 10.1111/liv.12606] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.1] [Reference Citation Analysis]
64 Woodall MC, Ciccarelli M, Woodall BP, Koch WJ. G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism. Circ Res 2014;114:1661-70. [PMID: 24812353 DOI: 10.1161/CIRCRESAHA.114.300513] [Cited by in Crossref: 58] [Cited by in F6Publishing: 54] [Article Influence: 7.3] [Reference Citation Analysis]
65 Huang ZM, Gao E, Chuprun JK, Koch WJ. GRK2 in the heart: a GPCR kinase and beyond. Antioxid Redox Signal 2014;21:2032-43. [PMID: 24702056 DOI: 10.1089/ars.2014.5876] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 2.6] [Reference Citation Analysis]
66 Liu S, Premont RT, Rockey DC. Endothelial nitric-oxide synthase (eNOS) is activated through G-protein-coupled receptor kinase-interacting protein 1 (GIT1) tyrosine phosphorylation and Src protein. J Biol Chem. 2014;289:18163-18174. [PMID: 24764294 DOI: 10.1074/jbc.m113.521203] [Cited by in Crossref: 28] [Cited by in F6Publishing: 26] [Article Influence: 3.5] [Reference Citation Analysis]
67 Watari K, Nakaya M, Kurose H. Multiple functions of G protein-coupled receptor kinases. J Mol Signal. 2014;9:1. [PMID: 24597858 DOI: 10.1186/1750-2187-9-1] [Cited by in Crossref: 55] [Cited by in F6Publishing: 57] [Article Influence: 6.9] [Reference Citation Analysis]
68 Taguchi K, Sakata K, Ohashi W, Imaizumi T, Imura J, Hattori Y. Tonic Inhibition by G Protein–Coupled Receptor Kinase 2 of Akt/Endothelial Nitric-Oxide Synthase Signaling in Human Vascular Endothelial Cells under Conditions of Hyperglycemia with High Insulin Levels. J Pharmacol Exp Ther 2014;349:199-208. [DOI: 10.1124/jpet.113.211854] [Cited by in Crossref: 26] [Cited by in F6Publishing: 25] [Article Influence: 3.3] [Reference Citation Analysis]
69 Avendaño MS, Lucas E, Jurado-Pueyo M, Martínez-Revelles S, Vila-Bedmar R, Mayor F Jr, Salaices M, Briones AM, Murga C. Increased nitric oxide bioavailability in adult GRK2 hemizygous mice protects against angiotensin II-induced hypertension. Hypertension 2014;63:369-75. [PMID: 24191280 DOI: 10.1161/HYPERTENSIONAHA.113.01991] [Cited by in Crossref: 33] [Cited by in F6Publishing: 30] [Article Influence: 3.7] [Reference Citation Analysis]
70 Huang ZM, Gao E, Fonseca FV, Hayashi H, Shang X, Hoffman NE, Chuprun JK, Tian X, Tilley DG, Madesh M, Lefer DJ, Stamler JS, Koch WJ. Convergence of G protein-coupled receptor and S-nitrosylation signaling determines the outcome to cardiac ischemic injury. Sci Signal 2013;6:ra95. [PMID: 24170934 DOI: 10.1126/scisignal.2004225] [Cited by in Crossref: 38] [Cited by in F6Publishing: 63] [Article Influence: 4.2] [Reference Citation Analysis]
71 Rivas V, Carmona R, Muñoz-Chápuli R, Mendiola M, Nogués L, Reglero C, Miguel-Martín M, García-Escudero R, Dorn GW 2nd, Hardisson D, Mayor F Jr, Penela P. Developmental and tumoral vascularization is regulated by G protein-coupled receptor kinase 2. J Clin Invest 2013;123:4714-30. [PMID: 24135140 DOI: 10.1172/JCI67333] [Cited by in Crossref: 45] [Cited by in F6Publishing: 43] [Article Influence: 5.0] [Reference Citation Analysis]
72 Robinson JD, Pitcher JA. G protein-coupled receptor kinase 2 (GRK2) is a Rho-activated scaffold protein for the ERK MAP kinase cascade. Cell Signal 2013;25:2831-9. [PMID: 24018045 DOI: 10.1016/j.cellsig.2013.08.031] [Cited by in Crossref: 35] [Cited by in F6Publishing: 29] [Article Influence: 3.9] [Reference Citation Analysis]
73 Ciccarelli M, Sorriento D, Franco A, Fusco A, Del Giudice C, Annunziata R, Cipolletta E, Monti MG, Dorn GW 2nd, Trimarco B, Iaccarino G. Endothelial G protein-coupled receptor kinase 2 regulates vascular homeostasis through the control of free radical oxygen species. Arterioscler Thromb Vasc Biol 2013;33:2415-24. [PMID: 23950144 DOI: 10.1161/ATVBAHA.113.302262] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 2.6] [Reference Citation Analysis]
74 Xing W, Li Y, Zhang H, Mi C, Hou Z, Quon MJ, Gao F. Improvement of vascular insulin sensitivity by downregulation of GRK2 mediates exercise-induced alleviation of hypertension in spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 2013;305:H1111-9. [PMID: 23913704 DOI: 10.1152/ajpheart.00290.2013] [Cited by in Crossref: 24] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
75 Fan Q, Chen M, Zuo L, Shang X, Huang MZ, Ciccarelli M, Raake P, Brinks H, Chuprun KJ, Dorn GW 2nd, Koch WJ, Gao E. Myocardial Ablation of G Protein-Coupled Receptor Kinase 2 (GRK2) Decreases Ischemia/Reperfusion Injury through an Anti-Intrinsic Apoptotic Pathway. PLoS One 2013;8:e66234. [PMID: 23805205 DOI: 10.1371/journal.pone.0066234] [Cited by in Crossref: 39] [Cited by in F6Publishing: 44] [Article Influence: 4.3] [Reference Citation Analysis]
76 Liu S, Rockey DC. Cicletanine stimulates eNOS phosphorylation and NO production via Akt and MAP kinase/Erk signaling in sinusoidal endothelial cells. Am J Physiol Gastrointest Liver Physiol. 2013;305:G163-G171. [PMID: 23639812 DOI: 10.1152/ajpgi.00003.2013] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
77 Aliev G, Obrenovich ME, Tabrez S, Jabir NR, Reddy VP, Li Y, Burnstock G, Cacabelos R, Kamal MA. Link between cancer and Alzheimer disease via oxidative stress induced by nitric oxide-dependent mitochondrial DNA overproliferation and deletion. Oxid Med Cell Longev 2013;2013:962984. [PMID: 23691268 DOI: 10.1155/2013/962984] [Cited by in Crossref: 29] [Cited by in F6Publishing: 24] [Article Influence: 3.2] [Reference Citation Analysis]
78 Santulli G, Trimarco B, Iaccarino G. G-protein-coupled receptor kinase 2 and hypertension: molecular insights and pathophysiological mechanisms. High Blood Press Cardiovasc Prev 2013;20:5-12. [PMID: 23532739 DOI: 10.1007/s40292-013-0001-8] [Cited by in Crossref: 88] [Cited by in F6Publishing: 81] [Article Influence: 9.8] [Reference Citation Analysis]
79 Hu LS, George J, Wang JH. Current concepts on the role of nitric oxide in portal hypertension. World J Gastroenterol 2013; 19(11): 1707-1717 [PMID: 23555159 DOI: 10.3748/wjg.v19.i11.1707] [Cited by in CrossRef: 47] [Cited by in F6Publishing: 40] [Article Influence: 5.2] [Reference Citation Analysis]
80 Chen M, Sato PY, Chuprun JK, Peroutka RJ, Otis NJ, Ibetti J, Pan S, Sheu SS, Gao E, Koch WJ. Prodeath signaling of G protein-coupled receptor kinase 2 in cardiac myocytes after ischemic stress occurs via extracellular signal-regulated kinase-dependent heat shock protein 90-mediated mitochondrial targeting. Circ Res 2013;112:1121-34. [PMID: 23467820 DOI: 10.1161/CIRCRESAHA.112.300754] [Cited by in Crossref: 85] [Cited by in F6Publishing: 94] [Article Influence: 9.4] [Reference Citation Analysis]
81 Haldar SM, Stamler JS. S-nitrosylation: integrator of cardiovascular performance and oxygen delivery. J Clin Invest 2013;123:101-10. [PMID: 23281416 DOI: 10.1172/JCI62854] [Cited by in Crossref: 79] [Cited by in F6Publishing: 82] [Article Influence: 8.8] [Reference Citation Analysis]
82 Taguchi K, Matsumoto T, Kamata K, Kobayashi T. Suppressed G-protein-coupled receptor kinase 2 activity protects female diabetic-mouse aorta against endothelial dysfunction. Acta Physiol (Oxf) 2013;207:142-55. [PMID: 22925038 DOI: 10.1111/j.1748-1716.2012.02473.x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.6] [Reference Citation Analysis]
83 Rengo G, Zincarelli C, Femminella GD, Liccardo D, Pagano G, de Lucia C, Altobelli GG, Cimini V, Ruggiero D, Perrone-Filardi P, Gao E, Ferrara N, Lymperopoulos A, Koch WJ, Leosco D. Myocardial β(2) -adrenoceptor gene delivery promotes coordinated cardiac adaptive remodelling and angiogenesis in heart failure. Br J Pharmacol 2012;166:2348-61. [PMID: 22452704 DOI: 10.1111/j.1476-5381.2012.01954.x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 36] [Article Influence: 3.1] [Reference Citation Analysis]
84 Håkansson G, Lutay N, Andersson M, Hallgren O, Westergren-Thorsson G, Svensson M, Godaly G. Epithelial G protein-coupled receptor kinases regulate the initial inflammatory response during mycobacterial infection. Immunobiology 2013;218:984-94. [PMID: 23312955 DOI: 10.1016/j.imbio.2012.11.001] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
85 Kamal FA, Travers JG, Blaxall BC. G protein-coupled receptor kinases in cardiovascular disease: why "where" matters. Trends Cardiovasc Med 2012;22:213-9. [PMID: 23062971 DOI: 10.1016/j.tcm.2012.07.023] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 2.0] [Reference Citation Analysis]
86 Otten JJ, de Jager SC, Kavelaars A, Seijkens T, Bot I, Wijnands E, Beckers L, Westra MM, Bot M, Busch M, Bermudez B, van Berkel TJ, Heijnen CJ, Biessen EA. Hematopoietic G-protein-coupled receptor kinase 2 deficiency decreases atherosclerotic lesion formation in LDL receptor-knockout mice. FASEB J 2013;27:265-76. [PMID: 23047899 DOI: 10.1096/fj.12-205351] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.5] [Reference Citation Analysis]
87 Carnovale CE, Ronco MT. Role of nitric oxide in liver regeneration. Annals of Hepatology 2012;11:636-47. [DOI: 10.1016/s1665-2681(19)31436-x] [Cited by in Crossref: 31] [Cited by in F6Publishing: 18] [Article Influence: 3.1] [Reference Citation Analysis]
88 Taguchi K, Matsumoto T, Kamata K, Kobayashi T. G protein-coupled receptor kinase 2, with β-arrestin 2, impairs insulin-induced Akt/endothelial nitric oxide synthase signaling in ob/ob mouse aorta. Diabetes 2012;61:1978-85. [PMID: 22688330 DOI: 10.2337/db11-1729] [Cited by in Crossref: 35] [Cited by in F6Publishing: 31] [Article Influence: 3.5] [Reference Citation Analysis]
89 Taguchi K, Matsumoto T, Kamata K, Kobayashi T. Inhibitor of G protein-coupled receptor kinase 2 normalizes vascular endothelial function in type 2 diabetic mice by improving β-arrestin 2 translocation and ameliorating Akt/eNOS signal dysfunction. Endocrinology 2012;153:2985-96. [PMID: 22581458 DOI: 10.1210/en.2012-1101] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.5] [Reference Citation Analysis]
90 Wei Z, Hurtt R, Ciccarelli M, Koch WJ, Doria C. Growth inhibition of human hepatocellular carcinoma cells by overexpression of G-protein-coupled receptor kinase 2. J Cell Physiol 2012;227:2371-7. [PMID: 21826651 DOI: 10.1002/jcp.22972] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 1.4] [Reference Citation Analysis]
91 Napolitano R, Campanile A, Sarno L, Anastasio A, Maruotti GM, Morlando M, Trimarco B, Martinelli P, Iaccarino G. GRK2 levels in umbilical arteries of pregnancies complicated by gestational hypertension and preeclampsia. Am J Hypertens 2012;25:366-71. [PMID: 22089113 DOI: 10.1038/ajh.2011.211] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
92 Liu S, Premont RT, Rockey DC. G-protein-coupled receptor kinase interactor-1 (GIT1) is a new endothelial nitric-oxide synthase (eNOS) interactor with functional effects on vascular homeostasis. J Biol Chem. 2012;287:12309-12320. [PMID: 22294688 DOI: 10.1074/jbc.m111.320465] [Cited by in Crossref: 27] [Cited by in F6Publishing: 27] [Article Influence: 2.7] [Reference Citation Analysis]
93 Evron T, Daigle TL, Caron MG. GRK2: multiple roles beyond G protein-coupled receptor desensitization. Trends Pharmacol Sci 2012;33:154-64. [PMID: 22277298 DOI: 10.1016/j.tips.2011.12.003] [Cited by in Crossref: 102] [Cited by in F6Publishing: 97] [Article Influence: 10.2] [Reference Citation Analysis]
94 Seo YS, Shah VH. Pathophysiology of portal hypertension and its clinical links. J Clin Exp Hepatol 2011;1:87-93. [PMID: 25755320 DOI: 10.1016/S0973-6883(11)60127-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.8] [Reference Citation Analysis]
95 Taguchi K, Kobayashi T, Takenouchi Y, Matsumoto T, Kamata K. Angiotensin II causes endothelial dysfunction via the GRK2/Akt/eNOS pathway in aortas from a murine type 2 diabetic model. Pharmacological Research 2011;64:535-46. [DOI: 10.1016/j.phrs.2011.05.001] [Cited by in Crossref: 37] [Cited by in F6Publishing: 37] [Article Influence: 3.4] [Reference Citation Analysis]
96 Belmonte SL, Blaxall BC. G protein coupled receptor kinases as therapeutic targets in cardiovascular disease. Circ Res 2011;109:309-19. [PMID: 21778435 DOI: 10.1161/CIRCRESAHA.110.231233] [Cited by in Crossref: 81] [Cited by in F6Publishing: 76] [Article Influence: 7.4] [Reference Citation Analysis]
97 Gurevich EV, Tesmer JJ, Mushegian A, Gurevich VV. G protein-coupled receptor kinases: more than just kinases and not only for GPCRs. Pharmacol Ther. 2012;133:40-69. [PMID: 21903131 DOI: 10.1016/j.pharmthera.2011.08.001] [Cited by in Crossref: 275] [Cited by in F6Publishing: 264] [Article Influence: 25.0] [Reference Citation Analysis]
98 Taguchi K, Kobayashi T, Matsumoto T, Kamata K. Dysfunction of endothelium-dependent relaxation to insulin via PKC-mediated GRK2/Akt activation in aortas of ob/ob mice. American Journal of Physiology-Heart and Circulatory Physiology 2011;301:H571-83. [DOI: 10.1152/ajpheart.01189.2010] [Cited by in Crossref: 33] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
99 Guturu P, Shah V. New insights into the pathobiology of portal hypertension. Hepatol Res 2009;39:1016-9. [PMID: 19796039 DOI: 10.1111/j.1872-034X.2009.00553.x] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 1.1] [Reference Citation Analysis]
100 Kim MY, Baik SK, Lee SS. Hemodynamic alterations in cirrhosis and portal hypertension. Korean J Hepatol 2010;16:347-52. [PMID: 21415576 DOI: 10.3350/kjhep.2010.16.4.347] [Cited by in Crossref: 58] [Cited by in F6Publishing: 56] [Article Influence: 5.3] [Reference Citation Analysis]
101 Huang ZM, Gold JI, Koch WJ. G protein-coupled receptor kinases in normal and failing myocardium. Front Biosci (Landmark Ed) 2011;16:3047-60. [PMID: 21622221 DOI: 10.2741/3898] [Cited by in Crossref: 43] [Cited by in F6Publishing: 51] [Article Influence: 3.9] [Reference Citation Analysis]
102 Mayor F Jr, Lucas E, Jurado-Pueyo M, Garcia-Guerra L, Nieto-Vazquez I, Vila-Bedmar R, Fernández-Veledo S, Murga C. G Protein-coupled receptor kinase 2 (GRK2): A novel modulator of insulin resistance. Arch Physiol Biochem 2011;117:125-30. [PMID: 21615207 DOI: 10.3109/13813455.2011.584693] [Cited by in Crossref: 25] [Cited by in F6Publishing: 23] [Article Influence: 2.3] [Reference Citation Analysis]
103 Ciccarelli M, Chuprun JK, Rengo G, Gao E, Wei Z, Peroutka RJ, Gold JI, Gumpert A, Chen M, Otis NJ, Dorn GW 2nd, Trimarco B, Iaccarino G, Koch WJ. G protein-coupled receptor kinase 2 activity impairs cardiac glucose uptake and promotes insulin resistance after myocardial ischemia. Circulation 2011;123:1953-62. [PMID: 21518983 DOI: 10.1161/CIRCULATIONAHA.110.988642] [Cited by in Crossref: 106] [Cited by in F6Publishing: 111] [Article Influence: 9.6] [Reference Citation Analysis]
104 Wang H, Heijnen CJ, Eijkelkamp N, Carbajal AG, Schedlowski M, Kelley KW, Dantzer R, Kavelaars A. GRK2 in sensory neurons regulates epinephrine-induced signalling and duration of mechanical hyperalgesia. Pain 2011;152:1649-58. [PMID: 21514055 DOI: 10.1016/j.pain.2011.03.010] [Cited by in Crossref: 34] [Cited by in F6Publishing: 38] [Article Influence: 3.1] [Reference Citation Analysis]
105 Kim MY, Baik SK. [Pathophysiology of portal hypertension, what's new?]. Korean J Gastroenterol 2010;56:129-34. [PMID: 20847603 DOI: 10.4166/kjg.2010.56.3.129] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
106 Völkers M, Weidenhammer C, Herzog N, Qiu G, Spaich K, Wegner FV, Peppel K, Müller OJ, Schinkel S, Rabinowitz JE, Hippe HJ, Brinks H, Katus HA, Koch WJ, Eckhart AD, Friedrich O, Most P. The inotropic peptide βARKct improves βAR responsiveness in normal and failing cardiomyocytes through G(βγ)-mediated L-type calcium current disinhibition. Circ Res 2011;108:27-39. [PMID: 21106943 DOI: 10.1161/CIRCRESAHA.110.225201] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 3.3] [Reference Citation Analysis]
107 Penela P, Murga C, Ribas C, Lafarga V, Mayor F Jr. The complex G protein-coupled receptor kinase 2 (GRK2) interactome unveils new physiopathological targets. Br J Pharmacol 2010;160:821-32. [PMID: 20590581 DOI: 10.1111/j.1476-5381.2010.00727.x] [Cited by in Crossref: 151] [Cited by in F6Publishing: 153] [Article Influence: 12.6] [Reference Citation Analysis]
108 García-Calderó H, Rodríguez-Vilarrupla A, Gracia-Sancho J, Diví M, Laviña B, Bosch J, García-Pagán JC. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats. J Hepatol 2011;54:660-5. [PMID: 21159403 DOI: 10.1016/j.jhep.2010.07.034] [Cited by in Crossref: 29] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
109 Shimada H, Staten NR, Rajagopalan LE. TGF-β1 mediated activation of Rho kinase induces TGF-β2 and endothelin-1 expression in human hepatic stellate cells. J Hepatol. 2011;54:521-528. [PMID: 21087804 DOI: 10.1016/j.jhep.2010.07.026] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
110 Brinks H, Boucher M, Gao E, Chuprun JK, Pesant S, Raake PW, Huang ZM, Wang X, Qiu G, Gumpert A, Harris DM, Eckhart AD, Most P, Koch WJ. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms. Circ Res 2010;107:1140-9. [PMID: 20814022 DOI: 10.1161/CIRCRESAHA.110.221010] [Cited by in Crossref: 101] [Cited by in F6Publishing: 92] [Article Influence: 8.4] [Reference Citation Analysis]
111 Zhou RH, Pesant S, Cohn HI, Soltys S, Koch WJ, Eckhart AD. Negative regulation of VEGF signaling in human coronary artery endothelial cells by G protein-coupled receptor kinase 5. Clin Transl Sci 2009;2:57-61. [PMID: 20443868 DOI: 10.1111/j.1752-8062.2008.00058.x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
112 Ufer C, Germack R. Cross-regulation between beta 1- and beta 3-adrenoceptors following chronic beta-adrenergic stimulation in neonatal rat cardiomyocytes. Br J Pharmacol 2009;158:300-13. [PMID: 19719783 DOI: 10.1111/j.1476-5381.2009.00328.x] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.1] [Reference Citation Analysis]
113 Zheng Y, Liu J, Li X, Xu L. Effects and mechanism of Weinaokang (维脑康) on reperfusioninduced vascular injury to cerebral microvessels after global cerebral ischemia. Chin J Integr Med 2010;16:145-50. [DOI: 10.1007/s11655-010-0145-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 0.8] [Reference Citation Analysis]
114 Lee KC, Yang YY, Huang YT, Lee FY, Hou MC, Lin HC, Lee SD. Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability. Clin Sci (Lond). 2010;119:45-55. [PMID: 20132096 DOI: 10.1042/cs20090601] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 2.1] [Reference Citation Analysis]
115 Obrenovich ME, Palacios HH, Gasimov E, Leszek J, Aliev G. The GRK2 Overexpression Is a Primary Hallmark of Mitochondrial Lesions during Early Alzheimer Disease. Cardiovasc Psychiatry Neurol 2009;2009:327360. [PMID: 20204079 DOI: 10.1155/2009/327360] [Cited by in Crossref: 20] [Cited by in F6Publishing: 22] [Article Influence: 1.7] [Reference Citation Analysis]
116 Brinks HL, Eckhart AD. Regulation of GPCR signaling in hypertension. Biochim Biophys Acta 2010;1802:1268-75. [PMID: 20060896 DOI: 10.1016/j.bbadis.2010.01.005] [Cited by in Crossref: 56] [Cited by in F6Publishing: 59] [Article Influence: 4.7] [Reference Citation Analysis]
117 Patial S, Luo J, Porter KJ, Benovic JL, Parameswaran N. G-protein-coupled-receptor kinases mediate TNFα-induced NFκB signalling via direct interaction with and phosphorylation of IκBα. Biochem J 2009;425:169-78. [PMID: 19796012 DOI: 10.1042/BJ20090908] [Cited by in Crossref: 76] [Cited by in F6Publishing: 80] [Article Influence: 5.8] [Reference Citation Analysis]
118 Vollmar B, Menger MD. The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev. 2009;89:1269-1339. [PMID: 19789382 DOI: 10.1152/physrev.00027.2008] [Cited by in Crossref: 287] [Cited by in F6Publishing: 301] [Article Influence: 22.1] [Reference Citation Analysis]
119 Mohammadi MS, Thabut D, Cazals-Hatem D, Galbois A, Rudler M, Bonnefont-Rousselot D, Moreau R, Lebrec D, Tazi KA. Possible mechanisms involved in the discrepancy of hepatic and aortic endothelial nitric oxide synthases during the development of cirrhosis in rats. Liver Int. 2009;29:692-700. [PMID: 19040541 DOI: 10.1111/j.1478-3231.2008.01909.x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
120 Heitzler D, Crépieux P, Poupon A, Clément F, Fages F, Reiter E. Towards a systems biology approach of G protein-coupled receptor signalling: Challenges and expectations. Comptes Rendus Biologies 2009;332:947-57. [DOI: 10.1016/j.crvi.2009.09.002] [Cited by in Crossref: 19] [Cited by in F6Publishing: 13] [Article Influence: 1.5] [Reference Citation Analysis]
121 Campanile A, Iaccarino G. G-protein-coupled receptor kinases in cardiovascular conditions: focus on G-protein-coupled receptor kinase 2, a gain in translational medicine. Biomarkers in Medicine 2009;3:525-40. [DOI: 10.2217/bmm.09.50] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.3] [Reference Citation Analysis]
122 Foster MW, Hess DT, Stamler JS. Protein S-nitrosylation in health and disease: a current perspective. Trends Mol Med. 2009;15:391-404. [PMID: 19726230 DOI: 10.1016/j.molmed.2009.06.007] [Cited by in Crossref: 522] [Cited by in F6Publishing: 503] [Article Influence: 40.2] [Reference Citation Analysis]
123 Theodorakis NG, Wang YN, Wu JM, Maluccio MA, Sitzmann JV, Skill NJ. Role of endothelial nitric oxide synthase in the development of portal hypertension in the carbon tetrachloride-induced liver fibrosis model. Am J Physiol Gastrointest Liver Physiol. 2009;297:G792-G799. [PMID: 19628654 DOI: 10.1152/ajpgi.00229.2009] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 1.1] [Reference Citation Analysis]
124 Ushio-Fukai M. Vascular signaling through G protein-coupled receptors: new concepts. Curr Opin Nephrol Hypertens 2009;18:153-9. [PMID: 19434053 DOI: 10.1097/MNH.0b013e3283252efe] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
125 Cho YK, Yun JW, Park JH, Kim HJ, Park DI, Sohn CI, Jeon WK, Kim BI, Jin W, Kwon YH, Shin MK, Yoo TM, Kang JH, Park CS. Deleterious effects of silymarin on the expression of genes controlling endothelial nitric oxide synthase activity in carbon tetrachloride-treated rat livers. Life Sci 2009;85:281-90. [PMID: 19527736 DOI: 10.1016/j.lfs.2009.06.001] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
126 Feng HQ, Weymouth ND, Rockey DC. Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease. Am J Physiol Gastrointest Liver Physiol. 2009;297:G27-G33. [PMID: 19299580 DOI: 10.1152/ajpgi.90405.2008] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 3.0] [Reference Citation Analysis]
127 Shah V. Therapy for portal hypertension: What is our pipeline? Hepatology 2009;49:4-5. [PMID: 19108005 DOI: 10.1002/hep.22687] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]
128 Sorriento D, Ciccarelli M, Santulli G, Campanile A, Altobelli GG, Cimini V, Galasso G, Astone D, Piscione F, Pastore L, Trimarco B, Iaccarino G. The G-protein-coupled receptor kinase 5 inhibits NFkappaB transcriptional activity by inducing nuclear accumulation of IkappaB alpha. Proc Natl Acad Sci U S A 2008;105:17818-23. [PMID: 19008357 DOI: 10.1073/pnas.0804446105] [Cited by in Crossref: 90] [Cited by in F6Publishing: 82] [Article Influence: 6.4] [Reference Citation Analysis]
129 Obrenovich ME, Morales LA, Cobb CJ, Shenk JC, Méndez GM, Fischbach K, Smith MA, Qasimov EK, Perry G, Aliev G. Insights into cerebrovascular complications and Alzheimer disease through the selective loss of GRK2 regulation. J Cell Mol Med 2009;13:853-65. [PMID: 19292735 DOI: 10.1111/j.1582-4934.2008.00512.x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 0.6] [Reference Citation Analysis]
130 Ozawa K, Whalen EJ, Nelson CD, Mu Y, Hess DT, Lefkowitz RJ, Stamler JS. S-nitrosylation of beta-arrestin regulates beta-adrenergic receptor trafficking. Mol Cell 2008;31:395-405. [PMID: 18691971 DOI: 10.1016/j.molcel.2008.05.024] [Cited by in Crossref: 135] [Cited by in F6Publishing: 126] [Article Influence: 9.6] [Reference Citation Analysis]
131 Harris DM, Cohn HI, Pesant S, Eckhart AD. GPCR signalling in hypertension: role of GRKs. Clin Sci (Lond) 2008;115:79-89. [PMID: 18593382 DOI: 10.1042/CS20070442] [Cited by in Crossref: 51] [Cited by in F6Publishing: 45] [Article Influence: 3.6] [Reference Citation Analysis]
132 Hu Z, Chen J, Wei Q, Xia Y. Bidirectional actions of hydrogen peroxide on endothelial nitric-oxide synthase phosphorylation and function: co-commitment and interplay of Akt and AMPK. J Biol Chem 2008;283:25256-63. [PMID: 18617528 DOI: 10.1074/jbc.M802455200] [Cited by in Crossref: 52] [Cited by in F6Publishing: 52] [Article Influence: 3.7] [Reference Citation Analysis]
133 Angelone T, Quintieri AM, Brar BK, Limchaiyawat PT, Tota B, Mahata SK, Cerra MC. The antihypertensive chromogranin a peptide catestatin acts as a novel endocrine/paracrine modulator of cardiac inotropism and lusitropism. Endocrinology 2008;149:4780-93. [PMID: 18535098 DOI: 10.1210/en.2008-0318] [Cited by in Crossref: 109] [Cited by in F6Publishing: 103] [Article Influence: 7.8] [Reference Citation Analysis]
134 Matei V, Rodríguez-Vilarrupla A, Deulofeu R, García-Calderó H, Fernández M, Bosch J, Garcia-Pagán JC. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats. J Hepatol. 2008;49:192-197. [PMID: 18534709 DOI: 10.1016/j.jhep.2008.04.014] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 2.3] [Reference Citation Analysis]
135 Mazza R, Gattuso A, Mannarino C, Brar BK, Barbieri SF, Tota B, Mahata SK. Catestatin (chromogranin A344-364) is a novel cardiosuppressive agent: inhibition of isoproterenol and endothelin signaling in the frog heart. Am J Physiol Heart Circ Physiol 2008;295:H113-22. [PMID: 18469147 DOI: 10.1152/ajpheart.00172.2008] [Cited by in Crossref: 50] [Cited by in F6Publishing: 47] [Article Influence: 3.6] [Reference Citation Analysis]
136 Iwakiri Y, Grisham M, Shah V. Vascular biology and pathobiology of the liver: Report of a single-topic symposium. Hepatology 2008;47:1754-63. [PMID: 18393322 DOI: 10.1002/hep.22203] [Cited by in Crossref: 42] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
137 Nijboer CH, Kavelaars A, Vroon A, Groenendaal F, van Bel F, Heijnen CJ. Low endogenous G-protein-coupled receptor kinase 2 sensitizes the immature brain to hypoxia-ischemia-induced gray and white matter damage. J Neurosci 2008;28:3324-32. [PMID: 18367599 DOI: 10.1523/JNEUROSCI.4769-07.2008] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
138 Edwards C, Feng HQ, Reynolds C, Mao L, Rockey DC. Effect of the nitric oxide donor V-PYRRO/NO on portal pressure and sinusoidal dynamics in normal and cirrhotic mice. Am J Physiol Gastrointest Liver Physiol. 2008;294:G1311-G1317. [PMID: 18356534 DOI: 10.1152/ajpgi.00368.2007] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
139 Anegawa G, Kawanaka H, Yoshida D, Konishi K, Yamaguchi S, Kinjo N, Taketomi A, Hashizume M, Shimokawa H, Maehara Y. Defective endothelial nitric oxide synthase signaling is mediated by rho-kinase activation in rats with secondary biliary cirrhosis. Hepatology 2008;47:966-77. [PMID: 18167063 DOI: 10.1002/hep.22089] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 2.4] [Reference Citation Analysis]
140 Shah V. Molecular mechanisms of increased intrahepatic resistance in portal hypertension. J Clin Gastroenterol. 2007;41 Suppl 3:S259-S261. [PMID: 17975474 DOI: 10.1097/mcg.0b013e318150d0e1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 1.6] [Reference Citation Analysis]
141 Rockey DC. Noninvasive assessment of liver fibrosis and portal hypertension with transient elastography. Gastroenterology 2008;134:8-14. [PMID: 18166342 DOI: 10.1053/j.gastro.2007.11.053] [Cited by in Crossref: 103] [Cited by in F6Publishing: 97] [Article Influence: 7.4] [Reference Citation Analysis]
142 Kleibeuker W, Jurado-pueyo M, Murga C, Eijkelkamp N, Mayor Jr F, Heijnen CJ, Kavelaars A. Physiological changes in GRK2 regulate CCL2-induced signaling to ERK1/2 and Akt but not to MEK1/2 and calcium. Journal of Neurochemistry 2008;104:979-92. [DOI: 10.1111/j.1471-4159.2007.05023.x] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 1.5] [Reference Citation Analysis]
143 Thabut D, Tazi KA, Bonnefont-Rousselot D, Aller M, Farges O, Guimont MC, Tellier Z, Guichard C, Ogier-Denis E, Poynard T, Moreau R, Lebrec D. High-density lipoprotein administration attenuates liver proinflammatory response, restores liver endothelial nitric oxide synthase activity, and lowers portal pressure in cirrhotic rats. Hepatology 2007;46:1893-906. [PMID: 17918268 DOI: 10.1002/hep.21875] [Cited by in Crossref: 49] [Cited by in F6Publishing: 44] [Article Influence: 3.3] [Reference Citation Analysis]
144 Lee NH, Haas BJ, Letwin NE, Frank BC, Luu TV, Sun Q, House CD, Yerga-woolwine S, Farms P, Manickavasagam E, Joe B. Cross-Talk of Expression Quantitative Trait Loci Within 2 Interacting Blood Pressure Quantitative Trait Loci. Hypertension 2007;50:1126-33. [DOI: 10.1161/hypertensionaha.107.093138] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 0.5] [Reference Citation Analysis]
145 Harris DM, Cohn HI, Pesant S, Zhou R, Eckhart AD. Vascular smooth muscle G q signaling is involved in high blood pressure in both induced renal and genetic vascular smooth muscle-derived models of hypertension. American Journal of Physiology-Heart and Circulatory Physiology 2007;293:H3072-9. [DOI: 10.1152/ajpheart.00880.2007] [Cited by in Crossref: 22] [Cited by in F6Publishing: 23] [Article Influence: 1.5] [Reference Citation Analysis]
146 Whalen EJ, Foster MW, Matsumoto A, Ozawa K, Violin JD, Que LG, Nelson CD, Benhar M, Keys JR, Rockman HA, Koch WJ, Daaka Y, Lefkowitz RJ, Stamler JS. Regulation of beta-adrenergic receptor signaling by S-nitrosylation of G-protein-coupled receptor kinase 2. Cell 2007;129:511-22. [PMID: 17482545 DOI: 10.1016/j.cell.2007.02.046] [Cited by in Crossref: 231] [Cited by in F6Publishing: 215] [Article Influence: 15.4] [Reference Citation Analysis]
147 Enrico O, Gabriele B, Nadia C, Sara G, Daniele V, Giulia C, Antonio S, Mario P. Unexpected cardiotoxicity in haematological bortezomib treated patients. Br J Haematol 2007;138:396-7. [PMID: 17561972 DOI: 10.1111/j.1365-2141.2007.06659.x] [Cited by in Crossref: 144] [Cited by in F6Publishing: 136] [Article Influence: 9.6] [Reference Citation Analysis]
148 Lombardi MS, Vroon A, Sodaar P, van Muiswinkel FL, Heijnen CJ, Kavelaars A. Down-regulation of GRK2 after oxygen and glucose deprivation in rat hippocampal slices: role of the PI3-kinase pathway. J Neurochem 2007;102:731-40. [PMID: 17437535 DOI: 10.1111/j.1471-4159.2007.04576.x] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 0.7] [Reference Citation Analysis]
149 Reichen J, Lebrec D. The future treatment of portal hypertension. Best Pract Res Clin Gastroenterol. 2007;21:191-202. [PMID: 17223505 DOI: 10.1016/j.bpg.2006.07.006] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
150 Aird WC. Phenotypic heterogeneity of the endothelium: II. Representative vascular beds. Circ Res 2007;100:174-90. [PMID: 17272819 DOI: 10.1161/01.RES.0000255690.03436.ae] [Cited by in Crossref: 668] [Cited by in F6Publishing: 643] [Article Influence: 44.5] [Reference Citation Analysis]
151 Beaulieu JM, Gainetdinov RR, Caron MG. The Akt-GSK-3 signaling cascade in the actions of dopamine. Trends Pharmacol Sci. 2007;28:166-172. [PMID: 17349698 DOI: 10.1016/j.tips.2007.02.006] [Cited by in Crossref: 281] [Cited by in F6Publishing: 285] [Article Influence: 18.7] [Reference Citation Analysis]
152 Iwakiri Y, Groszmann RJ. Vascular endothelial dysfunction in cirrhosis. J Hepatol 2007;46:927-34. [PMID: 17391799 DOI: 10.1016/j.jhep.2007.02.006] [Cited by in Crossref: 202] [Cited by in F6Publishing: 174] [Article Influence: 13.5] [Reference Citation Analysis]
153 Tang L, Luo B, Patel RP, Ling Y, Zhang J, Fallon MB. Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome. Am J Physiol Lung Cell Mol Physiol. 2007;292:L1467-L1472. [PMID: 17337507 DOI: 10.1152/ajplung.00446.2006] [Cited by in Crossref: 33] [Cited by in F6Publishing: 35] [Article Influence: 2.2] [Reference Citation Analysis]
154 Zheng Y, Liu J, Wang J, Xu L. Effects of crocin on reperfusion-induced oxidative/nitrative injury to cerebral microvessels after global cerebral ischemia. Brain Research 2007;1138:86-94. [DOI: 10.1016/j.brainres.2006.12.064] [Cited by in Crossref: 140] [Cited by in F6Publishing: 143] [Article Influence: 9.3] [Reference Citation Analysis]
155 Rockey DC. Hepatic fibrosis, stellate cells, and portal hypertension. Clin Liver Dis. 2006;10:459-479, vii-viii. [PMID: 17162223 DOI: 10.1016/j.cld.2006.08.017] [Cited by in Crossref: 77] [Cited by in F6Publishing: 73] [Article Influence: 5.1] [Reference Citation Analysis]
156 De Minicis S, Seki E, Uchinami H, Kluwe J, Zhang Y, Brenner DA, Schwabe RF. Gene expression profiles during hepatic stellate cell activation in culture and in vivo. Gastroenterology. 2007;132:1937-1946. [PMID: 17484886 DOI: 10.1053/j.gastro.2007.02.033] [Cited by in Crossref: 292] [Cited by in F6Publishing: 323] [Article Influence: 19.5] [Reference Citation Analysis]
157 Abraldes JG, Rodríguez-Vilarrupla A, Graupera M, Zafra C, García-Calderó H, García-Pagán JC, Bosch J. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats. J Hepatol. 2007;46:1040-1046. [PMID: 17335931 DOI: 10.1016/j.jhep.2007.01.020] [Cited by in Crossref: 150] [Cited by in F6Publishing: 143] [Article Influence: 10.0] [Reference Citation Analysis]
158 Hennenberg M, Trebicka J, Biecker E, Schepke M, Sauerbruch T, Heller J. Vascular dysfunction in human and rat cirrhosis: role of receptor-desensitizing and calcium-sensitizing proteins. Hepatology 2007;45:495-506. [PMID: 17256744 DOI: 10.1002/hep.21502] [Cited by in Crossref: 57] [Cited by in F6Publishing: 55] [Article Influence: 3.8] [Reference Citation Analysis]
159 Rosskopf D, Schürks M, Rimmbach C, Schäfers R. Genetics of arterial hypertension and hypotension. Naunyn Schmiedebergs Arch Pharmacol 2007;374:429-69. [PMID: 17262198 DOI: 10.1007/s00210-007-0133-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 1.9] [Reference Citation Analysis]
160 Yang W, Xia SH. Mechanisms of regulation and function of G-protein-coupled receptor kinases. World J Gastroenterol 2006; 12(48): 7753-7757 [PMID: 17203515 DOI: 10.3748/wjg.v12.i48.7753] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 8] [Article Influence: 0.8] [Reference Citation Analysis]
161 Hansen JL, Theilade J, Aplin M, Sheikh SP. Role of G-protein-coupled receptor kinase 2 in the heart--do regulatory mechanisms open novel therapeutic perspectives? Trends Cardiovasc Med 2006;16:169-77. [PMID: 16781951 DOI: 10.1016/j.tcm.2006.03.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 17] [Article Influence: 0.9] [Reference Citation Analysis]
162 Obrenovich ME, Smith MA, Siedlak SL, Chen SG, de la Torre JC, Perry G, Aliev G. Overexpression of GRK2 in Alzheimer disease and in a chronic hypoperfusion rat model is an early marker of brain mitochondrial lesions. Neurotox Res 2006;10:43-56. [PMID: 17000469 DOI: 10.1007/BF03033333] [Cited by in Crossref: 45] [Cited by in F6Publishing: 45] [Article Influence: 2.8] [Reference Citation Analysis]
163 Ribas C, Penela P, Murga C, Salcedo A, García-Hoz C, Jurado-Pueyo M, Aymerich I, Mayor F. The G protein-coupled receptor kinase (GRK) interactome: role of GRKs in GPCR regulation and signaling. Biochim Biophys Acta. 2007;1768:913-922. [PMID: 17084806 DOI: 10.1016/j.bbamem.2006.09.019] [Cited by in Crossref: 267] [Cited by in F6Publishing: 259] [Article Influence: 16.7] [Reference Citation Analysis]
164 Vroon A, Heijnen CJ, Kavelaars A. GRKs and arrestins: regulators of migration and inflammation. J Leukoc Biol 2006;80:1214-21. [PMID: 16943386 DOI: 10.1189/jlb.0606373] [Cited by in Crossref: 113] [Cited by in F6Publishing: 113] [Article Influence: 7.1] [Reference Citation Analysis]
165 Feldman RD, Gros R. Defective vasodilatory mechanisms in hypertension: a G-protein-coupled receptor perspective. Curr Opin Nephrol Hypertens 2006;15:135-40. [PMID: 16481879 DOI: 10.1097/01.mnh.0000214772.96361.ef] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.5] [Reference Citation Analysis]
166 Nikitenko LL, Blucher N, Fox SB, Bicknell R, Smith DM, Rees MC. Adrenomedullin and CGRP interact with endogenous calcitonin-receptor-like receptor in endothelial cells and induce its desensitisation by different mechanisms. J Cell Sci 2006;119:910-22. [PMID: 16495482 DOI: 10.1242/jcs.02783] [Cited by in Crossref: 37] [Cited by in F6Publishing: 30] [Article Influence: 2.3] [Reference Citation Analysis]
167 Ren Q, Liao X, Wang Z, Qu Z, Wang J. The involvement of glycogen synthase kinase-3 and protein phosphatase-2A in lactacystin-induced tau accumulation. FEBS Letters 2006;580:2503-11. [DOI: 10.1016/j.febslet.2006.03.073] [Cited by in Crossref: 22] [Cited by in F6Publishing: 21] [Article Influence: 1.4] [Reference Citation Analysis]
168 Reiter E, Lefkowitz RJ. GRKs and beta-arrestins: roles in receptor silencing, trafficking and signaling. Trends Endocrinol Metab. 2006;17:159-165. [PMID: 16595179 DOI: 10.1016/j.tem.2006.03.008] [Cited by in Crossref: 470] [Cited by in F6Publishing: 426] [Article Influence: 29.4] [Reference Citation Analysis]
169 Langer DA, Shah VH. A gas, an amino acid, and an imposter: the story of nitric oxide, L-arginine, and ADMA in portal hypertension. Hepatology 2005;42:1255-7. [PMID: 16317700 DOI: 10.1002/hep.20989] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.2] [Reference Citation Analysis]